semaglutide prediabetes weight loss diabetes prevention trial SELECT Trial: reduces the risk of MACE by 20% in people with overweight or obesity, pre-existing CVD, and no diabetes. Average of -9.4% at 51 months GLP-1 Medications for Weight Loss:

How Semaglutide Works for Type 2 Diabetes A primary use of semaglutide is improved glycemic control, achieved by the peptides interaction with the GLP-1 receptors in the exocrine pancreas

Animal studies have demonstrated effects on gastric function, gut-brain signaling, and inflammatory pathways that overlap with some GLP-1 mechanisms

Demirel t, N., Ko Yldrm, S., Erbac, E

446 Studies suggest that for patients who respond poorly to mesalazine, sulfasalazine may provide an alternative that reduces inflammation and ulceration of the intestinal mucosa and possibly improves the local immune response

Moreover, the drug's tolerability was broadly in line with the current blockbuster